Financial ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results byJosh SandbergFebruary 28, 2024
Financial Spine Top Stories ZimVie Announces Definitive Agreement to Sell Spine Business to H.I.G. Capital for $375 Million byJosh SandbergDecember 18, 2023
Regulatory Spine ZimVie Announces Compatibility Between its Vital™ Spinal Fixation System and Brainlab Spine & Trauma Navigation byJosh SandbergDecember 12, 2023
Spine Top Stories ZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study byJosh SandbergSeptember 26, 2023
Spine ZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-Marketing byJosh SandbergAugust 17, 2023
Regulatory Spine Top Stories ZimVie Announces FDA Approval for New Mobi-C® Implant byJosh SandbergAugust 10, 2023
Financial ZimVie Reports Second Quarter 2023 Financial Results and Provides Update to Annual Guidance byJosh SandbergAugust 2, 2023
Spine Top Stories ZimVie Announces Expanded Reimbursement and Exemplary Clinical Rating for Mobi-C® byJosh SandbergApril 3, 2023
Spine Top Stories ZimVie Announces Additional Positive Policy Decisions for Vertebral Body Tethering byJosh SandbergMarch 15, 2023
Financial ZimVie Reports Fourth Quarter and Full Year 2022 Financial Results byJosh SandbergMarch 1, 2023
